H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 9.8% of adults in Norman have diagnosed diabetes — 2.2 points below the U.S. 12% figure. Census population 128,026. Oklahoma Medicare wound biologics: Novitas Solutions (JH). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Norman clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Norman storefront.
Diabetic Wound Care That Delivers in Norman, OK for clinics & physicians. Specialized diabetic wound care… Compliance support & pricing — contact Hawk Medical.
Two files matter before you open a box of diabetic wound care in Norman: (1) CDC PLACES (2023, crude) estimates 9.8% of adults in Norman have diagnosed diabetes — 2.2 points below the U.S. 12% figure. (2) Oklahoma Part B wound biologics are reviewed by Novitas Solutions under JH, shared with AR, CO, LA, MS, NM, TX. We help with the second file. We do not pretend to be a Norman storefront.
National Diabetic Wound Care That Delivers notes (how the product actually works)Oklahoma shares JH with AR, CO, LA, MS, NM, TX. Florida is the only single-state MAC. CDC PLACES (2023, crude) estimates 9.8% of adults in Norman have diagnosed diabetes — 2.2 points below the U.S. 12% figure. If you also operate in another contractor’s state, say so on the first call — we map both.
The 96.5% hematogel figure on our wound materials is product-level clinical experience, not a Norman trial. Local outcomes stay with the treating physician. CDC PLACES (2023, crude) estimates 9.8% of adults in Norman have diagnosed diabetes — 2.2 points below the U.S. 12% figure. Use that rate for inventory math, not for ads.
CDC PLACES (2023, crude prevalence) estimates 9.8% of adults — 2.2 points below the U.S. 12% figure. Obesity is 35.8%; arthritis is 22.7%. That is place-level BRFSS modeling, not a clinic census and not a Norman trial.
Oklahoma is not in CDC’s core Diabetes Belt list, but 12% national prevalence still means diabetic wounds will appear. Stock from your clinic mix, not from belt branding.
Yes. Tissue products come from FDA-registered banks with donor screening and lot traceability. Your receiving SOP should file IFU, lot, and indication with the chart. That packet is what JH reviewers and surveyors expect — not a brochure.
The allograft is used to perform the same basic function in the recipient as in the donor (FDA 361). Using umbilical or amniotic tissue as a marketed “stem cell cure” for unrelated conditions is outside that lane and is a Oklahoma compliance risk.
Bring specialty, monthly wound volume, and whether you bill JH FFS, Advantage, workers’ comp, or cash-pay. We already have PLACES 9.8% diabetes and 22.7% arthritis for Norman — tell us how that matches your panel. Book 15 minutes with Joe or use the contact form.
Contact us to learn how Hawk Medical supports practices in Norman, OK.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Norman is JH geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Norman — 2.2 points below the U.S. 12% figure. Planning input, not an outcomes claim.
Oklahoma Part B wound biologics follow this contractor (siblings: AR, CO, LA, MS, NM, TX). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Norman. Useful for joint-program math; still needs a diagnosis and privileging.
No Norman storefront. Joe Bradley is an active practice owner. diabetic wound care stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.